Related Experiment Video
Updated: Sep 27, 2025

Measuring TCR-pMHC Binding In Situ using a FRET-based Microscopy Assay
Published on: October 30, 2015
Monoclonal Antibodies as Probes to Study Ligand-Induced Conformations of Troponin Subunits
Monica Rasmussen1, Jian-Ping Jin1,2
1Department of Physiology, Wayne State University School of Medicine, Detroit, MI, United States.
Abstract:
Striated muscle contraction and relaxation is regulated by Ca2+ at the myofilament level via conformational modulations of the troponin complex. To understand the structure-function relationship of troponin in normal muscle and in myopathies, it is necessary to study the functional effects of troponin isoforms and mutations at the level of allosteric conformations of troponin subunits. Traditional methodologies assessing such conformational studies are laborious and require significant amounts of purified protein, while many current methodologies require non-physiological conditions or labeling of the protein, which may affect their physiological conformation and function. To address these issues, we developed a novel approach using site-specific monoclonal antibodies (mAb) as molecular probes to detect and monitor conformational changes of proteins. Here, we present examples for its application in studies of two subunits of troponin: the Ca2+-binding subunit, TnC, and the tropomyosin-binding/thin filament-anchoring subunit, TnT. Studies using a high-throughput microplate assay are compared with that using localized surface plasmon resonance (LSPR) to demonstrate the effectiveness of using mAb probes to assess ligand-induced conformations of troponin subunits in physiological conditions. The assays utilize relatively small amounts of protein and are free of protein modification, which may bias results. Detailed methodologies using various monoclonal antibodies (mAbs) are discussed with considerations for the optimization of assay conditions and the broader application in studies of other proteins as well as in screening of therapeutic reagents that bind a specific target site with conformational and functional effects.
Insights
Researchers developed a novel method using monoclonal antibodies (mAbs) to study troponin complex conformational changes. This technique offers a sensitive and physiologically relevant approach for muscle contraction research and disease studies.
Area of Science:
- Biochemistry
- Molecular Biology
- Muscle Physiology
Background:
- Striated muscle contraction relies on Ca2+ regulation of the troponin complex.
- Understanding troponin structure-function is crucial for muscle diseases, but traditional methods are limited.
- Existing methods often require large protein amounts, non-physiological conditions, or protein labeling.
Purpose of the Study:
- To develop and validate a novel approach for studying troponin subunit conformational changes.
- To assess ligand-induced allosteric conformations of troponin subunits under physiological conditions.
- To demonstrate the utility of site-specific monoclonal antibodies (mAbs) as molecular probes.
Main Methods:
- Development of a novel assay using site-specific monoclonal antibodies (mAbs) as molecular probes.
- Application of mAbs to study Ca2+-binding subunit (TnC) and tropomyosin-binding subunit (TnT) of troponin.
- Comparison of high-throughput microplate assays with localized surface plasmon resonance (LSPR) for mAb-based conformational analysis.
Main Results:
- Demonstrated the effectiveness of mAb probes in detecting ligand-induced conformational changes in troponin subunits.
- Showcased assays requiring minimal protein amounts and avoiding potentially biasing protein modifications.
- Validated the use of mAbs for studying troponin conformations under physiological conditions.
Conclusions:
- Monoclonal antibodies provide a powerful tool for studying protein conformational dynamics.
- The developed mAb-based assays are sensitive, require small protein amounts, and maintain physiological relevance.
- This approach has broad applications in studying protein structure-function relationships and screening therapeutic agents.

